|
2025
|
Invention
|
Anti-abeta antibody, antigen-binding fragment thereof and application thereof.
Murine, chimeric ... |
|
|
Invention
|
Amino-substituted heteroaromatic cyclic compound, preparation method therefor and use thereof in ... |
|
|
Invention
|
Dihydrofuro[3,4-f]quinazoline compound, preparation method therefor and use thereof in medicine. ... |
|
|
Invention
|
Anti-cldn6 antibody, antibody-drug conjugate comprising same and medical use thereof. The present... |
|
|
Invention
|
Crystalline form and salt of pyridine-n-oxide derivative, and use thereof. The present disclosure... |
|
|
Invention
|
Il-5 antibody, antigen binding fragment thereof, and medical application therefor.
Provided are ... |
|
|
Invention
|
Anti-cldn6 antibody, antibody-drug conjugate thereof, and medical use thereof. Provided are an an... |
|
|
Invention
|
Pharmaceutically acceptable salt of g12d inhibitor compound and crystal form thereof. The present... |
|
|
Invention
|
Crystal form of g12d inhibitor compound and preparation method. The present invention relates to ... |
|
|
Invention
|
Glp-1r agonist pharmaceutical composition and use thereof. Disclosed are a GLP-1R agonist pharmac... |
|
2024
|
Invention
|
Antibody-polypeptide conjugate and pharmaceutical use thereof. An antibody-polypeptide conjugate ... |
|
|
Invention
|
Pharmaceutical composition comprising bispecific antibody specifically binding dll3 and cd3. Prov... |
|
|
Invention
|
Olefin compound, preparation method therefor and use thereof in medicine. The present disclosure ... |
|
|
Invention
|
Cd3-targeting antibody and use thereof. The present invention provides an antibody specifically b... |
|
|
Invention
|
Heterocyclic compound, and preparation method therefor and use thereof in medicine. The present d... |
|
|
Invention
|
Method for preparing heterologous multimer by means of recombination reaction. The present disclo... |
|
|
Invention
|
Fused heteroaryl compound, preparation method therefor, and use thereof in medicine. The present ... |
|
|
Invention
|
Pharmaceutical composition of sulfonylurea derivative. The present disclosure provides a pharmace... |
|
|
Invention
|
Pharmaceutical composition comprising anti-tslp antibody and use thereof. The present invention r... |
|
|
Invention
|
Amide-substituted cycloalkyl compounds, preparation method therefor and medical uses thereof. The... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystalline form of quinazoline derivative, and use thereof.... |
|
|
Invention
|
Crystalline form of quinazoline derivative and preparation method therefor. A crystalline form of... |
|
|
Invention
|
Heterocyclic compound, preparation method therefor and medical use thereof. The present disclosur... |
|
|
Invention
|
Heteroaryl compound, and preparation method therefor and use thereof in medicine. Provided are a ... |
|
|
Invention
|
Pharmaceutical composition comprising bispecific antibody specifically binding to gprc5d and cd3.... |
|
|
Invention
|
Fused heteroaryl compound, and preparation method therefor and use thereof in medicine. A fused h... |
|
|
Invention
|
Heteroaryl compound, preparation method therefor, and use thereof in medicine. A heteroaryl compo... |
|
|
Invention
|
Anti-psma antibody-drug conjugate and pharmaceutical use thereof. An anti-PSMA antibody-drug conj... |
|
|
Invention
|
Anti-npr1 antibody and pharmaceutical use thereof. Provided are an anti-NPR1 antibody, a pharmace... |
|
|
Invention
|
Amorphous substance and crystal of dioxopiperidine compound or pharmaceutically acceptable salt t... |
|
2023
|
Invention
|
Crystal forms of triazine dione derivative and preparation method therefor.
The present disclosu... |
|
|
Invention
|
Nitrogen-containing heterocyclic compound, preparation method therefor, and pharmaceutical applic... |
|
|
Invention
|
Fused heterocyclic compound, and preparation method therefor and medical use thereof.
The presen... |
|
|
Invention
|
Antigen-binding molecule specifically binding to gprc5d and cd3 and medical use thereof.
Provide... |
|
|
Invention
|
Antigen-binding molecule specifically binding to psma and cd3, and pharmaceutical use thereof.
P... |
|
|
Invention
|
Crystalline form of sulfur-containing isoindoline derivative.
The present disclosure relates to ... |
|
2022
|
Invention
|
Anti-ror1 antibody, and anti-ror1 antibody-drug conjugate and medical uses thereof.
An anti-ROR1... |
|
|
Invention
|
Anti-dll3 antibody and pharmaceutical use thereof, and antibody-drug conjugate containing anti-dl... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystalline form of glp-1 receptor agonist and preparation m... |
|
|
Invention
|
Crystalline form of glp-1 receptor agonist and preparation method therefor.
A crystalline form o... |
|
|
Invention
|
Anti-sost antibody pharmaceutical composition and use thereof.
The present invention relates to ... |
|
|
Invention
|
Chimeric compound for targeted degradation of androgen receptor protein, preparation method there... |
|
|
Invention
|
Nitrogen-containing tetracyclic compound, preparation method therefor, and medical use thereof.
... |
|
|
Invention
|
Anti-il23 antibody fusion protein and uses thereof.
An anti-IL23 antibody fusion protein and use... |
|
|
Invention
|
Fused bicyclic derivative, pharmaceutically acceptable salt, crystal form thereof and preparation... |
|
|
Invention
|
Sulfonamide derivative, preparation method therefor and medical use thereof.
Provided is a sulfo... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystal form of fused pyridine ring derivative and preparati... |
|
|
Invention
|
Antigen-binding molecule.
Provided is an antigen-binding molecule, particularly a domain-enginee... |
|
|
Invention
|
Tetrahydronaphthalene compound, and preparation method therefor and use thereof in medicine.
The... |
|
2021
|
Invention
|
Nitrogen-containing bridged heterocyclic compound, preparation method therefor, and medical use t... |
